IL-6 additionally inhibits cytochrome P450 activity and accordingly can increase the bioavailability of many medications and worsen the drug–drug interactions and incline QTc/TdP arrhythmia [28, 41]. This evidence concerns the gene IL6 and Arrhythmia.